Scientists at Columbia University Vagelos College of Physicians and Surgeons present the most definitive evidence to date that the human brain makes new neurons throughout life.
Columbia neurologist William Kreisl, MD, explains the potential uses—and limitations—of a smell test in sniffing out Alzheimer's disease risk.
On average, patients see more than eight physicians before being diagnosed with a mitochondrial disease, a new CUIMC study finds.
A stroke education program that uses hip hop music increased stroke awareness among economically disadvantaged minority children and their parents.
Researchers from two Columbia University campuses have teamed up to develop a football helmet that detects concussion in real time.
Clinical trial shows that solanezumab, an antibody-based treatment for Alzheimer’s disease, does not significantly slow cognitive decline.